AI in Medicine: Short-lived Hype or New Era?
LMU professor Nikolaos Koutsouleris discusses AI's role in medicine, noting its potential for disease prediction and personalized treatment, but highlighting methodological and ethical challenges hindering widespread adoption.
Ludwig-Maximilians-Universität München (LMU) is examining the role of artificial intelligence (AI) in medicine, assessing its potential as a fleeting trend or the dawn of a new era in healthcare.
Nikolaos Koutsouleris, professor of medicine at LMU, explained in a lecture how the development of machine learning has transformed medical research. New AI-based analytics tools are enhancing the understanding of genetic predisposition, social environmental factors, and biological disease processes. AI is also acting as a catalyst for translating research into clinical applications more rapidly.
According to Koutsouleris, AI can be used to predict and prevent severe disease progression and plan individualized therapies. However, he emphasized that the implementation of these new tools is significantly hindered by methodological and infrastructural barriers, along with high regulatory and ethical requirements.
Professor Koutsouleris has focused on the prevention of mental illness using AI. His research group employs AI algorithms for risk assessment and to predict an individual's likelihood of developing severe mental health issues. The long-term goal is to shift the focus of psychiatric care towards a preventive model, enabling physicians to identify at-risk individuals more effectively and offer tailored preventive measures.
Widespread adoption of AI in medicine necessitates larger, high-quality datasets, transparency and reliability in AI models, analysis of systematic errors, and comparative testing across different health contexts. Addressing these challenges is crucial to fully realizing AI's potential in healthcare.